METHODS	Forty eight hours after each CHT 43/130 patients ( Group B ) were also administered 30 mg somatuline ( lanreotide ) by a single subcutaneous ( s.c. ) injection to stimulate somatostatin receptors ( SSTRS ) for 2 weeks .\